TY - JOUR
T1 - Administration of pyrene lipids by receptor-mediated endocytosis and their degradation in skin fibroblasts
AU - Agmon, Vered
AU - Dinur, Tama
AU - Cherbu, Sara
AU - Dagan, Arie
AU - Gatt, Shimon
N1 - Funding Information:
This work was supported in part by grants from the Deutsche Fors-chungs Gemeinschaft (FRG), March of Dimes (USA), Ministry for Science, and the Arts Niedersachsen, FRG, and The US-Israel Binational Science Foundation. We thank the following for generous gifts: Biotechnology General Inc., Nes-Ziona, Israel (for apolipoprotein E); Drs. D. Bishop and R. J. Desnick (for THC and Fabry disease kidney); Dr. G. Legler for bromoconduritol B epoxide); Dr. A. Preti (for DHC); Dr. G. Schwartzmann (for P12-GM3); Dr. S. Sonino (for P12-GMl); and Dr. M. Spence (for THC).
PY - 1991/10
Y1 - 1991/10
N2 - Sphingomyelin and seven glycosphingolipids were labeled with the fluorescent probe pyrene and administered into cultured fibroblasts by receptor-mediated endocytosis. For this purpose pyrene sphingomyelin or mixtures of pyrene glycolipid and unlabeled sphingomyelin were dispersed as small, unilamellar liposomes. Apolipoprotein E was then added and the receptor for this ligand on the cell surface was utilized for uptake of the liposomes and their transport to the lysosomes, where the respective pyrene lipids were degraded. Following incubation with each of the respective pyrene lipids, only the administered compound and the pyrene ceramide were present; intermediate hydrolysis products were not detected. This indicated that, in skin fibroblasts, the lysosomal ceramidase was limiting and controlled the rate of total degradation of the pyrene sphingolipids.
AB - Sphingomyelin and seven glycosphingolipids were labeled with the fluorescent probe pyrene and administered into cultured fibroblasts by receptor-mediated endocytosis. For this purpose pyrene sphingomyelin or mixtures of pyrene glycolipid and unlabeled sphingomyelin were dispersed as small, unilamellar liposomes. Apolipoprotein E was then added and the receptor for this ligand on the cell surface was utilized for uptake of the liposomes and their transport to the lysosomes, where the respective pyrene lipids were degraded. Following incubation with each of the respective pyrene lipids, only the administered compound and the pyrene ceramide were present; intermediate hydrolysis products were not detected. This indicated that, in skin fibroblasts, the lysosomal ceramidase was limiting and controlled the rate of total degradation of the pyrene sphingolipids.
UR - http://www.scopus.com/inward/record.url?scp=0025938228&partnerID=8YFLogxK
U2 - 10.1016/0014-4827(91)90244-O
DO - 10.1016/0014-4827(91)90244-O
M3 - Article
C2 - 1654269
AN - SCOPUS:0025938228
SN - 0014-4827
VL - 196
SP - 151
EP - 157
JO - Experimental Cell Research
JF - Experimental Cell Research
IS - 2
ER -